Carcinogenesis Program Direction Changes Near for Extramural research; Workshop Topics Listed
In Brief: Best Guess On NCI Director: Brown First Choice, Benacerraf Second; FDa On Saccharin
NCI Advisory Groups To Be Cut By One-Third
Graalman Objects To Criticism On Contract Competition
Abstracts Of Papers From Conference On Adjuvant Therapy
Trending Stories
- Karen Knudsen to leave ACS
- A $150M gift enables City of Hope to establish $1M Stephenson Prize in pancreatic cancer research, build research program focused on the disease
- Factors outside CAR T-cell therapy are associated with increased risk of secondary cancers after the treatment, meta-analysis shows
Subgroup analysis suggests risk of secondary cancers after CAR T-cell therapy is similar to risk after other therapies - Jeffrey S. Weber, pioneering immunologist and melanoma expert at NYU, dies at 72
- Tumors are able to form with no DNA mutations, fly study shows
- From clinician scientist to nonprofit CEO